文献速递头颈外科

伴心脏病甲状腺癌患者的围手术期临床治疗经验

[Clinical treatment experience of thyroid cancer with heart disease].
PubMed 文献 · Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi · 2019-01-01

回顾性分析39例伴心脏病的甲状腺癌患者,术前用心脏超声LVEF、冠脉CT、BNP等多指标评估心功能并给予相应治疗,39例均在全麻下完成甲状腺癌根治术,仅1例术后3天出现心衰,经治疗好转出院,提示围手术期风险评估与管理后可安全手术。

要点

  • 术前联合LVEF、冠脉CT、BNP等多指标评估心功能。
  • LVEF<40%或BNP>400 ng/L者先强心利尿营养心肌治疗1周。
  • 围手术期管理后甲状腺癌根治术可安全施行。

核心结论

  • 术前多指标充分评估心脏功能并改善心功能后,伴心脏病的甲状腺癌患者可安全施行规范的甲状腺癌手术。

研究设计与样本

  • 回顾性分析2014年4月至2018年2月北京安贞医院耳鼻咽喉头颈外科收治的伴心脏病甲状腺癌患者39例,男25例、女14例,年龄59~75岁,平均67.3±6.2岁。

主要发现

  • 39例均在全麻下完成手术,其中全甲状腺切除32例、腺叶及峡部切除7例、侧颈清扫23例(40侧)。
  • 1例术后3天出现心衰,强心利尿治疗2周后好转出院,余38例未发生围手术期心脏相关事件及脑血管、肺脏血栓。
  • 0≤BNP<100 ng/L且50%≤LVEF<60%组与0≤BNP<100 ng/L且36%≤LVEF<50%组麻醉准备时间差异有统计学意义(t=-8.884,P<0.001)。

关键数值与推荐

  • 术前LVEF分布:50%≤LVEF<60%者26例,40%≤LVEF<50%者10例,36%≤LVEF<40%者3例。
  • 术前BNP分布:0≤BNP<100 ng/L者27例,100≤BNP<400 ng/L者7例,400≤BNP<700 ng/L者5例。
  • 冠脉CT显示无冠脉狭窄>75%,搭桥血管通畅,支架术后冠脉通畅。
  • 对LVEF<40%的3例及400≤BNP<700 ng/L的5例,应用强心、利尿、营养心肌治疗1周。

临床怎么用

  • 术前应联合心脏超声LVEF、冠脉CT及BNP等指标充分评估心功能,并对心功能较差者先行强心利尿等治疗。
  • 围手术期采用低分子肝素替代口服抗凝等管理,做好风险评估后可施行规范的甲状腺癌手术。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To explore the perioperative clinical treatment of thyroid cancer patients with heart disease. Methods: A retrospective analysis was conducted on 39 thyroid cancer patients with heart disease admitted to the Department of Otorhinolaryngology Head and Neck Surgery, Beijing Anzhen Hospital,Capital Medical University from April 2014 to February 2018,including 25 males and 14 females, the age ranged from 59 to 75 years,with an average age of 67.3±6.2 years. Perioperative clinical monitoring indicators included cardiac ultrasound left ventricular ejection fraction (LVEF), degree of vascular stenosis revealed by coronary CT, hypersensitive troponin I (TNI), b-type natriuretic peptide (BNP), fibrinogen degradation products,and coagulation indexes. This panel of patients comprised 26 cases with 50% ≤ LVEF<60%,10 cases with 40% ≤ LVEF<50%, 3 cases with 36% ≤ LVEF<40%, 27 cases with 0≤BNP<100 ng/L, 7 cases with 100≤BNP<400 ng/L, and 5 cases with 400≤BNP<700 ng/L. Coronary CT showed no coronary artery stenosis>75%. The vascular graft was patent and the coronary artery after stenting was unobstructed. For 3 patients with LVEF<40% and 5 patients with BNP>400 ng/L,cardiotonic,diuretic,and nutritional myocardial therapy were used for 1 week. SPSS 17.0 software was used to analyze the data. Results: All 39 patients successfully completed the operation under general anesthesia,including 32 cases of total thyroidectomy,7 cases of glandular lobe and isthmic resection,and 40 cases of lateral neck dissection. One patient developed heart failure three days after surgery and was discharged after two weeks of treatment. No other cardiac related events,cerebrovascular and pulmonary thrombosis occurred during the perioperative period. The anesthesia preparation time was significant different between the group with 0≤BNP<100 ng/L and 50%≤LVEF<60% and the group with 0≤BNP<100 ng/L and 36%≤LVEF<50%. Conclusions: Multi-indicators were utilized to adequately assess cardiac function before surgery. According to the results of cardiac ultrasound and coronary CT examination, the corresponding treatment should be conducted to improve the cardiac function. After the perioperative risk assessment and management of thyroid cancer patients with heart disease,standardized thyroid cancer surgery can be performed safely. 目的: 探讨伴有心脏疾病的甲状腺癌患者围手术期临床治疗经验。 方法: 以2014年4月至2018年2月在首都医科大学附属北京安贞医院耳鼻咽喉头颈外科收治的伴有心脏疾病的39例甲状腺癌患者为研究对象进行回顾性分析,其中男25例,女14例;年龄在59~75岁,平均年龄(67.3±6.2)岁。围手术期临床监测指标包括:心脏超声左心室射血分数(LVEF)、冠状动脉(冠脉)CT显示的血管狭窄程度、实验室检查超敏肌钙蛋白I(TNI)、B型利钠肽(BNP)、纤维蛋白原降解产物、凝血指标等。50%≤LVEF<60%的26例;40%≤LVEF<50%的10例;36% ≤LVEF<40%的3例。术前冠脉CT检查显示无3支冠脉狭窄>75%,搭桥血管通畅,支架术后冠脉通畅。0≤BNP<100 ng/L的患者27例,100 ng/L≤BNP<400 ng/L的患者7例,400 ng/L≤BNP<700 ng/L的患者5例。围手术期用药包括采用低分子肝素替代口服抗凝等。对于LVEF<40%的3例患者及400≤BNP<700 ng/L的5例患者,应用强心、利尿、营养心肌治疗1周。以SPSS 17.0软件对数据进行统计分析。 结果: 39例患者均在全麻下顺利完成甲状腺癌根治术,其中全甲状腺切除32例,腺叶及峡部切除7例;侧颈清扫23例(40侧)。39例患者中1例术后3 d出现心衰,给予强心、利尿等治疗2周后好转出院。余38例未发生围手术期心脏相关事件及脑血管、肺脏血栓。0≤BNP<100 ng/L且50%≤LVEF<60%组与0≤BNP<100 ng/L且36%≤LVEF<50%组麻醉准备时间差异有统计学意义(t=-8.884,P<0.001)。 结论: 术前应用多指标充分评估心脏功能,参考心脏超声与冠脉CT检查结果,进行改善心脏功能治疗;做好伴有心脏疾病的甲状腺癌患者围手术期的风险评估与管理,可安全施行规范的甲状腺癌手术。.

来源:Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Wang JH, Zhao LY, Lyu YF, et al. [Clinical treatment experience of thyroid cancer with heart disease]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2019. PMID: 31262110. doi:10.3760/cma.j.issn.1673-0860.2019.05.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。